bf/NASDAQ:MOBX_icon.jpeg

COM:MOBIXLABS

Mobix Labs

  • Stock

USD

Last Close

0.58

22/11 21:00

Market Cap

40.78M

Beta: -

Volume Today

372.11K

Avg: -

Company Overview

Metric
Company NameMobix Labs, Inc.Visionlaser
SymbolMOBX
MSH IDCOM:MOBIXLABSBR:COM:VISIONLASER
MarketSTOCKSPRIVATE
SectorTechnologyTechnology
IndustrySemiconductorsWeb Development
CountryUSBR
Stage
Employee Count
Websitemobixlabs.comvisionlaser.com.br
LinkedInmobix-labs
Founders

Market Metrics

Metric
Market Cap40.78M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue1.22M
Revenue (LTM)
Revenue (NTM)
Gross Profit-396K
EBITDA-34.25M
Operating Income-35.54M
Net Income-39.62M
EPS-2.71
Diluted EPS-2.71
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.22
Operating Profit Margin-10.18
EBITDA Margin-27.99
Net Profit Margin-4.14
Return on Equity-2.92
Return on Assets-0.39
Return on Capital Employed-2.18

Valuation Multiples

Metric
P/E Ratio-3.33
P/B Ratio9.32
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio103.23
EV Multiple-0.47

Operational Metrics

Metric
Days Sales Outstanding347.73
Days Payables Outstanding4.07K
Days Inventory Outstanding228.85
Operating Cycle366.43
Cash Conversion Cycle-902.91
Asset Turnover0.09

Cash Flow Metrics

Metric
Operating Cash Flow-14.63M
Free Cash Flow-15.26M
Cash Flow to Debt-1.08
Operating Cash Flow/Sales-3.00
Free Cash Flow Yield-0.14

Balance Sheet Metrics

Metric
Cash & Equivalents89K
Accounts Receivable385K
Inventory319K
Goodwill5.22M
Debt to Capitalization0.60
Debt to Assets0.16
Current Ratio0.74
Quick Ratio0.70

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue58.31
R&D to Revenue13.23
SG&A to Revenue